CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets

3.3. Porters five forces analysis
3.4. Top player positioning, 2017
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Rise in prevalence of infectious diseases and cancer
3.5.1.2. Increase in awareness and acceptance of personalized medicines
3.5.1.3. Technological Advancements

3.5.2. Restraints

3.5.2.1. High cost of digital PCR devices
3.5.2.2. Reimbursement issues

3.5.3. Opportunity

3.5.3.1. Increase in funding for R&D activities

CHAPTER 4: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY

4.1. Overview

4.1.1. Market size and forecast

4.2. Droplet Digital PCR

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country

4.3. BEAMing Digital PCR

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

CHAPTER 5: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TYPE

5.1. Overview

5.1.1. Market size and forecast

5.2. Consumables and reagents

5.2.1. Market size and forecast
5.2.2. Market analysis, by country

5.3. Digital PCR equipment

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

5.4. Software & services

5.4.1. Market size and forecast
5.4.2. Market analysis, by country

CHAPTER 6: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY APPLICATION

6.1. Overview

6.1.1. Market size and forecast

6.2. Research

6.2.1. Market size and forecast
6.2.2. Market analysis, by country

6.3. Clinical diagnostics

6.3.1. Market size and forecast
6.3.2. Market analysis, by country

6.4. Forensics

6.4.1. Market size and forecast
6.4.2. Market analysis, by country

CHAPTER 7: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY END USER

7.1. Overview

7.1.1. Market size and forecast

7.2. Clinical diagnostic laboratories

7.2.1. Market size and forecast
7.2.2. Market analysis, by country

7.3. Pharmaceuticals & biotechnology industries

7.3.1. Market size and forecast
7.3.2. Market analysis, by country

7.4. University & research organizations

7.4.1. Market size and forecast
7.4.2. Market analysis, by country

CHAPTER 8: DIGITAL PCR MARKET, BY REGION

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. North America

8.2.1. Key market trends and opportunities
8.2.2. North America digital PCR market, by country

8.2.2.1. U.S. digital PCR market, by technology
8.2.2.2. U.S. digital PCR market, by type
8.2.2.3. U.S. digital PCR market, by application
8.2.2.4. U.S. digital PCR market, by end user
8.2.2.5. Canada digital PCR market, by technology
8.2.2.6. Canada digital PCR market, by type
8.2.2.7. Canada digital PCR market, by application
8.2.2.8. Canada digital PCR market, by end user
8.2.2.9. Mexico digital PCR market, by technology
8.2.2.10. Mexico digital PCR market, by type
8.2.2.11. Mexico digital PCR market, by application
8.2.2.12. Mexico digital PCR market, by end user

8.2.3. North America digital PCR market, by technology
8.2.4. North America digital PCR market, by type
8.2.5. North America digital PCR market, by application
8.2.6. North America digital PCR market, by end user

8.3. Europe

8.3.1. Key market trends and opportunities
8.3.2. Europe digital PCR market, by country

8.3.2.1. Germany digital PCR market, by technology
8.3.2.2. Germany digital PCR market, by type
8.3.2.3. Germany digital PCR market, by application
8.3.2.4. Germany digital PCR market, by end user
8.3.2.5. France digital PCR market, by technology
8.3.2.6. France digital PCR market, by type
8.3.2.7. France digital PCR market, by application
8.3.2.8. France digital PCR market, by end user
8.3.2.9. UK digital PCR market, by technology
8.3.2.10. UK digital PCR market, by type
8.3.2.11. UK digital PCR market, by application
8.3.2.12. UK digital PCR market, by end user
8.3.2.13. Italy digital PCR market, by technology
8.3.2.14. Italy digital PCR market, by type
8.3.2.15. Italy digital PCR market, by application
8.3.2.16. Italy digital PCR market, by end user
8.3.2.17. Spain digital PCR market, by technology
8.3.2.18. Spain digital PCR market, by type
8.3.2.19. Spain digital PCR market, by application
8.3.2.20. Spain digital PCR market, by end user
8.3.2.21. Rest of Europe digital PCR market, by technology
8.3.2.22. Rest of Europe digital PCR market, by type
8.3.2.23. Rest of Europe digital PCR market, by application
8.3.2.24. Rest of Europe digital PCR market, by end user

8.3.3. Europe digital PCR market, by technology
8.3.4. Europe digital PCR market, by type
8.3.5. Europe digital PCR market, by application
8.3.6. Europe digital PCR market, by end user

8.4. Asia-Pacific

8.4.1. Key market trends and opportunities
8.4.2. Asia-Pacific digital PCR market, by country

8.4.2.1. Japan digital PCR market, by technology
8.4.2.2. Japan digital PCR market, by type
8.4.2.3. Japan digital PCR market, by application
8.4.2.4. Japan digital PCR market, by end user
8.4.2.5. China digital PCR market, by technology
8.4.2.6. China digital PCR market, by type
8.4.2.7. China digital PCR market, by application
8.4.2.8. China digital PCR market, by end user
8.4.2.9. Australia digital PCR market, by technology
8.4.2.10. Australia digital PCR market, by type
8.4.2.11. Australia digital PCR market, by application
8.4.2.12. Australia digital PCR market, by end user
8.4.2.13. India digital PCR market, by technology
8.4.2.14. India digital PCR market, by type
8.4.2.15. India digital PCR market, by application
8.4.2.16. India digital PCR market, by end user
8.4.2.17. South Korea digital PCR market, by technology
8.4.2.18. South Korea digital PCR market, by type
8.4.2.19. South Korea digital PCR market, by application
8.4.2.20. South Korea digital PCR market, by end user
8.4.2.21. Taiwan digital PCR market, by technology
8.4.2.22. Taiwan digital PCR market, by type
8.4.2.23. Taiwan digital PCR market, by application
8.4.2.24. Taiwan digital PCR market, by end user
8.4.2.25. Rest of Asia-Pacific digital PCR market, by technology
8.4.2.26. Rest of Asia-Pacific digital PCR market, by type
8.4.2.27. Rest of Asia-Pacific digital PCR market, by application
8.4.2.28. Rest of Asia-Pacific digital PCR market, by end user

8.4.3. Asia-Pacific digital PCR market, by technology
8.4.4. Asia-Pacific digital PCR market, by type
8.4.5. Asia-Pacific digital PCR market, by application
8.4.6. Asia-Pacific digital PCR market, by end user

8.5. LAMEA

8.5.1. Key market trends and opportunities
8.5.2. LAMEA digital PCR market, by country

8.5.2.1. Brazil digital PCR market, by technology
8.5.2.2. Brazil digital PCR market, by type
8.5.2.3. Brazil digital PCR market, by application
8.5.2.4. Brazil digital PCR market, by end user
8.5.2.5. Saudi Arabia digital PCR market, by technology
8.5.2.6. Saudi Arabia digital PCR market, by type
8.5.2.7. Saudi Arabia digital PCR market, by application
8.5.2.8. Saudi Arabia digital PCR market, by end user
8.5.2.9. South Africa digital PCR market, by technology
8.5.2.10. South Africa digital PCR market, by type
8.5.2.11. South Africa digital PCR market, by application
8.5.2.12. South Africa digital PCR market, by end user
8.5.2.13. Rest of LAMEA digital PCR market, by technology
8.5.2.14. Rest of LAMEA digital PCR market, by type
8.5.2.15. Rest of LAMEA digital PCR market, by application
8.5.2.16. Rest of LAMEA digital PCR market, by end user

8.5.3. LAMEA digital PCR market, by technology
8.5.4. LAMEA digital PCR market, by type
8.5.5. LAMEA digital PCR market, by application
8.5.6. LAMEA digital PCR market, by end user

CHAPTER 9: COMPANY PROFILES

9.1. BIO-RAD LABORATORIES, INC. (RAINDANCE TECHNOLOGIES, INC.)

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.1.5. Key strategic moves and developments

9.2. EXPEDEON AG

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance

9.3. FLUIDIGM CORPORATION

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance

9.4. JN MEDSYS

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Key strategic moves and developments

9.5. MERCK KGAA

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments

9.6. QIAGEN N.V. (FORMULATRIX, INC.)

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.6.5. Key strategic moves and developments

9.7. STILLA TECHNOLOGIES

9.7.1. Company overview
9.7.2. Company snapshot

9.8. SYSMEX CORPORATION (SYSMEX INOSTICS GMBH)

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Business performance

9.9. THERMO FISHER SCIENTIFIC, INC.

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance